TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
TROY, Mich., Oct. 25, 2016 -- DirectRx Pharmacy, a leading independent pharmacy accredited by URAC, ACHC, NABP and WBENC, has won a competitive bid for nebulizers and related supplies from the Centers for Medicare & Medicaid Services (CMS) under Round 1 2017 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) competitive bidding program. The contract will apply from January 1, 2017 through December 31, 2018.
Under the new CMS contract, DirectRx Pharmacy will supply nebulizer equipment and supplies for Medicare clients in Kansas City, Mo. and Dearborn, Franklin, Ohio and Union counties, Ind. DirectRx specializes in treating COPD and other respiratory conditions using integrated care and follow-up, as well as leading medications such as Brovana, Budesonide and Perforomist.
“DirectRx is proud to be awarded this contract so that we can further our vision of helping patients with respiratory conditions such as asthma and COPD,” said Amanda Berishaj, PharmD, of DirectRx. “COPD, chronic bronchitis, emphysema and other respiratory conditions can be treated. With COPD, the key is treating the condition early to improve how well your lungs work.”
The DMEPOS Competitive Bidding Program was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The Centers for Medicare & Medicaid Services, CMS, is part of the Department of Health and Human Services (HHS).
DirectRx Pharmacy, an independent, family-owned pharmacy accredited by URAC, ACHC, NABP and WBENC, is dedicated to providing patients with unparalleled, personalized pharmaceutical care for their specialty pharmacy needs. Unlike other pharmacies, DirectRx is owned and operated by certified doctors of pharmacy. The company has grown to serve more than 38 states since its inception more than two decades ago. Investments in technology help to drive the best possible patient care and deliver the most accurate data to our partners. www.DirectRx.com
CONTACT: Amanda Berishaj, PharmD, DirectRx, (855) 362-3397
